Allianz Asset Management GmbH - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 205 filers reported holding HERON THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
Allianz Asset Management GmbH ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$887,000
-55.0%
155,085
-28.1%
0.00%0.0%
Q4 2021$1,972,000
-8.7%
215,644
+134.5%
0.00%
-50.0%
Q4 2019$2,161,000
-16.1%
91,948
-33.0%
0.00%
-33.3%
Q3 2019$2,575,000
-17.5%
137,208
-18.3%
0.00%0.0%
Q2 2019$3,122,000
-88.6%
167,953
-85.0%
0.00%
-88.9%
Q1 2019$27,324,000
-0.5%
1,117,985
+4.9%
0.03%
-10.0%
Q4 2018$27,459,000
-54.0%
1,066,263
-43.5%
0.03%
-44.4%
Q3 2018$59,736,000
+829.3%
1,887,391
+1040.8%
0.05%
+800.0%
Q2 2018$6,428,000
+115.8%
165,444
+53.3%
0.01%
+100.0%
Q1 2018$2,979,000
+50.2%
107,926
-1.5%
0.00%
+50.0%
Q4 2017$1,983,000
+11.9%
109,591
-0.1%
0.00%0.0%
Q3 2017$1,772,000
+16.5%
109,708
+0.0%
0.00%
+100.0%
Q2 2017$1,521,000
+8.0%
109,657
+17.6%
0.00%0.0%
Q1 2017$1,408,000
+14.9%
93,228
-0.3%
0.00%0.0%
Q4 2016$1,225,000
-57.5%
93,528
-44.3%
0.00%
-66.7%
Q3 2016$2,880,000
-25.8%
167,969
-21.8%
0.00%
-25.0%
Q2 2016$3,879,000
-56.8%
214,891
-54.5%
0.00%
-60.0%
Q1 2016$8,976,000
-26.5%
472,678
+5.8%
0.01%
-28.6%
Q4 2015$12,220,000
+219.1%
446,891
+184.7%
0.01%
+180.0%
Q3 2015$3,829,000
-72.4%
156,955
-83.6%
0.01%
-68.8%
Q1 2015$13,892,000954,7800.02%
Other shareholders
HERON THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
TANG KEVIN C 760$783100.00%
Velan Capital Investment Management LP 6,986,744$7,196,3465.80%
Tejara Capital Ltd 2,109,681$2,172,9711.23%
JW Asset Management, LLC 2,407,418$2,479,6411.07%
Rubric Capital Management LP 26,713,503$27,514,9081.03%
GREAT POINT PARTNERS LLC 4,737,368$4,879,4890.89%
Orchard Capital Management, LLC 2,142,823$2,207,1080.82%
Clearline Capital LP 6,149,842$6,334,3380.54%
CM Management, LLC 450,000$463,5000.49%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 327,450$337,2740.48%
View complete list of HERON THERAPEUTICS INC shareholders